Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Sci Rep ; 6: 31695, 2016 08 19.
Article in English | MEDLINE | ID: mdl-27538525

ABSTRACT

Otitis media (OM) is the most common childhood bacterial infection, and leading cause of conductive hearing loss. Nontypeable Haemophilus influenzae (NTHi) is a major bacterial pathogen for OM. OM characterized by the presence of overactive inflammatory responses is due to the aberrant production of inflammatory mediators including C-X-C motif chemokine ligand 5 (CXCL5). The molecular mechanism underlying induction of CXCL5 by NTHi is unknown. Here we show that NTHi up-regulates CXCL5 expression by activating IKKß-IκBα and p38 MAPK pathways via NF-κB nuclear translocation-dependent and -independent mechanism in middle ear epithelial cells. Current therapies for OM are ineffective due to the emergence of antibiotic-resistant NTHi strains and risk of side effects with prolonged use of immunosuppressant drugs. In this study, we show that curcumin, derived from Curcuma longa plant, long known for its medicinal properties, inhibited NTHi-induced CXCL5 expression in vitro and in vivo. Curcumin suppressed CXCL5 expression by direct inhibition of IKKß phosphorylation, and inhibition of p38 MAPK via induction of negative regulator MKP-1. Thus, identification of curcumin as a potential therapeutic for treating OM is of particular translational significance due to the attractiveness of targeting overactive inflammation without significant adverse effects.


Subject(s)
Chemokine CXCL5/biosynthesis , Curcumin/pharmacology , Dual Specificity Phosphatase 1/biosynthesis , Haemophilus Infections/metabolism , Haemophilus influenzae/metabolism , I-kappa B Kinase/metabolism , MAP Kinase Signaling System/drug effects , Up-Regulation/drug effects , A549 Cells , Haemophilus Infections/drug therapy , Haemophilus Infections/pathology , HeLa Cells , Humans , p38 Mitogen-Activated Protein Kinases/metabolism
2.
Acta Pharmacol Sin ; 35(1): 58-64, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24122011

ABSTRACT

AIM: Highly reactive carbonyl methylglyoxal (MGO) is one of the metabolites excessively produced in diabetes. We have showed that prolonged exposure of vascular smooth muscle cells to MGO leads to instability of the mRNA encoding ATP-sensitive potassium (KATP) channel. In the present study we investigated the effects of MGO on the activity of KATP channels. METHODS: Kir6.1/ SUR2B, Kir6.2/SUR2B or Kir6.2Δ36 (a truncated Kir6.2 isoform) alone was expressed in HEK293 cells. Whole-cell currents were recorded in the cells with an Axopatch 200B amplifier. Macroscopic currents and single-channel currents were recorded in giant inside-out patches and normal inside-out patches, respectively. Data were analyzed using Clampfit 9 software. RESULTS: The basal activity of Kir6.1/SUR2B channels was low. The specific KATP channel opener pinacidil (10 µmol/L) could fully activate Kir6.1/SUR2B channels, which was inhibited by the specific KATP channel blocker glibenclamide (10 µmol/L). MGO (0.1-10 mmol/L) dose-dependently activated Kir6.1/SUR2B channels with an EC50 of 1.7 mmol/L. The activation of Kir6.1/SUR2B channels by MGO was reversible upon washout, and could be inhibited completely by glibenclamide. Kir6.2Δ36 channels expressed in HEK293 cells could open automatically, and the channel activity was enhanced in the presence of MGO (3 mmol/L). Single channel recordings showed that MGO (3 mmol/L) markedly increased the open probability of Kir6.1/SUR2B channels, leaving the channel conductance unaltered. CONCLUSION: Acute application of MGO activates KATP channels through direct, non-covalent and reversible interactions with the Kir6 subunits.


Subject(s)
Gene Expression Regulation , KATP Channels/agonists , KATP Channels/metabolism , Pyruvaldehyde/administration & dosage , Animals , Dose-Response Relationship, Drug , HEK293 Cells , Humans , KATP Channels/biosynthesis , Mice , Rats , Time Factors
3.
Am J Physiol Cell Physiol ; 303(10): C1045-54, 2012 Nov 15.
Article in English | MEDLINE | ID: mdl-22972803

ABSTRACT

Diabetes mellitus is characterized by hyperglycemia and excessive production of intermediary metabolites including methylglyoxal (MGO), a reactive carbonyl species that can lead to cell injuries. Interacting with proteins, lipids, and DNA, excessive MGO can cause dysfunction of various tissues, especially the vascular walls where diabetic complications often take place. However, the potential vascular targets of excessive MGO remain to be fully understood. Here we show that the vascular Kir6.1/SUR2B isoform of ATP-sensitive K(+) (K(ATP)) channels is likely to be disrupted with an exposure to submillimolar MGO. Up to 90% of the Kir6.1/SUR2B currents were suppressed by 1 mM MGO with a time constant of ∼2 h. Consistently, MGO treatment caused a vast reduction of both Kir6.1 and SUR2B mRNAs endogenously expressed in the A10 vascular smooth muscle cells. In the presence of the transcriptional inhibitor actinomycin-D, MGO remained to lower the Kir6.1 and SUR2B mRNAs to the same degree as MGO alone, suggesting that the MGO effect is likely to compromise the mRNA stability. Luciferase reporter assays indicated that the 3'-untranslated regions (UTRs) of the Kir6.1 but not SUR2 mRNA were targeted by MGO. In contrast, the SUR2B mRNAs obtained with in vitro transcription were disrupted by MGO directly, while the Kir6.1 transcripts were unaffected. Consistent with these results, the constriction of mesenteric arterial rings was markedly augmented with an exposure to 1 mM MGO for 2 h, and such an MGO effect was totally eliminated in the presence of glibenclamide. These results therefore suggest that acting on the 3'-UTR of Kir6.1 and the coding region of SUR2B, MGO causes instability of Kir6.1 and SUR2B mRNAs, disruption of vascular K(ATP) channels, and impairment of arterial function.


Subject(s)
ATP-Binding Cassette Transporters/metabolism , KATP Channels/metabolism , Potassium Channels, Inwardly Rectifying/metabolism , Pyruvaldehyde/toxicity , RNA Stability/drug effects , RNA, Messenger/metabolism , Receptors, Drug/metabolism , ATP-Binding Cassette Transporters/genetics , Animals , Cloning, Molecular , Gene Expression Regulation/drug effects , HEK293 Cells , Humans , KATP Channels/genetics , Mesenteric Arteries/drug effects , Mesenteric Arteries/physiology , Patch-Clamp Techniques , Potassium Channels, Inwardly Rectifying/genetics , RNA, Messenger/genetics , Rats , Rats, Sprague-Dawley , Real-Time Polymerase Chain Reaction , Receptors, Drug/genetics , Reverse Transcriptase Polymerase Chain Reaction , Sulfonylurea Receptors , Vasoconstriction/drug effects
4.
J Immunol ; 188(12): 6371-80, 2012 Jun 15.
Article in English | MEDLINE | ID: mdl-22581859

ABSTRACT

Inflammation is a hallmark of many important human diseases. Appropriate inflammation is critical for host defense; however, an overactive response is detrimental to the host. Thus, inflammation must be tightly regulated. The molecular mechanisms underlying the tight regulation of inflammation remain largely unknown. Ecotropic viral integration site 1 (EVI1), a proto-oncogene and zinc finger transcription factor, plays important roles in normal development and leukemogenesis. However, its role in regulating NF-κB-dependent inflammation remains unknown. In this article, we show that EVI1 negatively regulates nontypeable Haemophilus influenzae- and TNF-α-induced NF-κB-dependent inflammation in vitro and in vivo. EVI1 directly binds to the NF-κB p65 subunit and inhibits its acetylation at lysine 310, thereby inhibiting its DNA-binding activity. Moreover, expression of EVI1 itself is induced by nontypeable Haemophilus influenzae and TNF-α in an NF-κB-dependent manner, thereby unveiling a novel inducible negative feedback loop to tightly control NF-κB-dependent inflammation. Thus, our study provides important insights into the novel role for EVI1 in negatively regulating NF-κB-dependent inflammation, and it may also shed light on the future development of novel anti-inflammatory strategies.


Subject(s)
DNA-Binding Proteins/metabolism , Feedback, Physiological/physiology , Inflammation/metabolism , NF-kappa B/metabolism , Transcription Factor RelA/metabolism , Transcription Factors/metabolism , Acetylation , Animals , Blotting, Western , Chromatin Immunoprecipitation , DNA-Binding Proteins/immunology , Electrophoretic Mobility Shift Assay , Haemophilus Infections/immunology , Haemophilus Infections/metabolism , Haemophilus influenzae/immunology , Immunoprecipitation , Inflammation/immunology , MDS1 and EVI1 Complex Locus Protein , Mice , Mice, Mutant Strains , NF-kappa B/immunology , Proto-Oncogene Mas , Proto-Oncogenes/immunology , RNA Interference , Real-Time Polymerase Chain Reaction , Transcription Factor RelA/immunology , Transcription Factors/immunology , Transfection , Tumor Necrosis Factor-alpha/immunology
5.
J Biol Chem ; 286(11): 9298-307, 2011 Mar 18.
Article in English | MEDLINE | ID: mdl-21216949

ABSTRACT

The vascular ATP-sensitive K(+) (K(ATP)) channel is targeted by a variety of vasoactive substances, playing an important role in vascular tone regulation. Our recent studies indicate that the vascular K(ATP) channel is inhibited in oxidative stress via S-glutathionylation. Here we show evidence for the molecular basis of the S-glutathionylation and its structural impact on channel gating. By comparing the oxidant responses of the Kir6.1/SUR2B channel with the Kir6.2/SUR2B channel, we found that the Kir6.1 subunit was responsible for oxidant sensitivity. Oxidant screening of Kir6.1-Kir6.2 chimeras demonstrated that the N terminus and transmembrane domains of Kir6.1 were crucial. Systematic mutational analysis revealed three cysteine residues in these domains: Cys(43), Cys(120), and Cys(176). Among them, Cys(176) was prominent, contributing to >80% of the oxidant sensitivity. The Kir6.1-C176A/SUR2B mutant channel, however, remained sensitive to both channel opener and inhibitor, which indicated that Cys(176) is not a general gating site in Kir6.1, in contrast to its counterpart (Cys(166)) in Kir6.2. A protein pull-down assay with biotinylated glutathione ethyl ester showed that mutation of Cys(176) impaired oxidant-induced incorporation of glutathione (GSH) into the Kir6.1 subunit. In contrast to Cys(176), Cys(43) had only a modest contribution to S-glutathionylation, and Cys(120) was modulated by extracellular oxidants but not intracellular GSSG. Simulation modeling of Kir6.1 S-glutathionylation suggested that after incorporation to residue 176, the GSH moiety occupied a space between the slide helix and two transmembrane helices. This prevented the inner transmembrane helix from undergoing conformational changes necessary for channel gating, retaining the channel in its closed state.


Subject(s)
Glutathione/metabolism , Ion Channel Gating/physiology , Potassium Channels, Inwardly Rectifying/metabolism , Amino Acid Substitution , Animals , Glutathione/genetics , Humans , KATP Channels , Mice , Mutation, Missense , Oxidation-Reduction , Potassium Channels, Inwardly Rectifying/genetics , Protein Structure, Secondary , Protein Structure, Tertiary , Rats , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...